177
Views
0
CrossRef citations to date
0
Altmetric
Articles

Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 364-370 | Received 27 Jul 2022, Accepted 03 Nov 2022, Published online: 23 Nov 2022

References

  • Locke FL, Ghobadi A, Jacobson CA, et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial. Lancet Oncol. 2019;20(1):31–42.
  • Park JH, Rivière I, Gonen M, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378(5):449–459.
  • Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625–638.
  • Mayer D. The survivorship tsunami: how will we be able to deliver psychosocial care to those in need. Paper presented at: 2018 American Psychosocial Oncology Society Annual Meeting; 2018.
  • Chakraborty R, Sidana S, Shah GL, et al. Patient-reported outcomes with chimeric antigen receptor T cell therapy: challenges and opportunities. Biol Blood Marrow Transplant. 2019;25(5):e155–e162.
  • Cancer ACoSCo. Cancer program standards 2012: ensuring patient-centered care. Illinois, USA: American College of Surgeons; 2012.
  • McNiff K. The quality oncology practice initiative: assessing and improving care within the medical oncology practice. J Oncol Pract. 2006;2(1):26–30.
  • American Cancer Society. What is a cancer caregiver? 2016. [Updated 2016 June 6; Accessed 2021]. Available from; https://www.cancer.org/treatment/caregivers/what-a-caregiver-does/who-and-what-are-caregivers.html.
  • Hodges L, Humphris G, Macfarlane G. A meta-analytic investigation of the relationship between the psychological distress of cancer patients and their carers. Soc Sci Med. 2005;60(1):1–12.
  • Barata A, Hoogland AI, Hyland KA, et al. Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy. Psychooncology. 2021;30(8):1294–1301.
  • Andrews SC. Caregiver burden and symptom distress in people with cancer receiving hospice care. Paper presented at oncology Nursing Forum. 2001.
  • Northouse LL, Katapodi MC, Schafenacker AM, et al. The impact of caregiving on the psychological well-being of family caregivers and cancer patients. Semin Oncol Nursing. 2012;28(4):236–245.
  • Hagedoorn M, Sanderman R, Bolks HN, et al. Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull. 2008;134(1):1–30.
  • Hirst M. Carer distress: a prospective, population-based study. Soc Sci Med. 2005;61(3):697–708.
  • Fenstermacher DA, Wenham RM, Rollison DE, et al. Implementing personalized medicine in a cancer center. Cancer J. 2011;17(6):528–536.
  • Harris PA, Taylor R, Minor BL, REDCap Consortium, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
  • Cook KF, Jensen SE, Schalet BD, et al. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol. 2016;73:89–102.
  • Cella D, Choi SW, Condon DM, et al. PROMIS® adult health profiles: efficient Short-Form measures of seven health domains. Value Health. 2019;22(5):537–544.
  • Wilford J, Osann K, Hsieh S, et al. Validation of PROMIS emotional distress short form scales for cervical cancer. Gynecol Oncol. 2018;151(1):111–116.
  • Bédard M, Molloy DW, Squire L, et al. The zarit burden interview: a new short version and screening version. Gerontologist. 2001;41(5):652–657.
  • Van Durme T, Macq J, Jeanmart C, et al. Tools for measuring the impact of informal caregiving of the elderly: a literature review. Int J Nurs Stud. 2012;49(4):490–504.
  • Higginson IJ, Gao W, Jackson D, et al. Short-form zarit caregiver burden interviews were valid in advanced conditions. J Clin Epidemiol. 2010;63(5):535–542.
  • Archbold PG, Stewart BJ, Greenlick MR, et al. Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health. 1990;13(6):375–384.
  • Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has Parkinson’s disease: the spouse’s perspective by stage of disease. Mov Disord. 1998;13(1):20–28.
  • Hudson PL, Hayman-White K. Measuring the psychosocial characteristics of family caregivers of palliative care patients: psychometric properties of nine self-report instruments. J Pain Symptom Manage. 2006;31(3):215–228.
  • O'Malley KA, Qualls SH. Preliminary evidence for the validity and reliability of the caregiver reaction scale. Clin Gerontol. 2017;40(4):281–294.
  • O’Malley KA, Qualls SH. Validation of a comprehensive measure of the family caregiver experience: the caregiver reaction scale. Clin Gerontol. 2022;45(3):503–513.
  • Albinger N, Hartmann J, Ullrich E. Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther. 2021;28(9):513–527.
  • Broers S, Kaptein AA, Le Cessie S, et al. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J Psychosom Res. 2000;48(1):11–21.
  • El-Jawahri AR, Traeger LN, Kuzmuk K, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015;121(6):951–959.
  • Winterling J, Kisch A, Alvariza A, et al. Preparedness for family caregiving prior to allogeneic hematopoietic stem cell transplantation. Palliat Support Care. 2022;20(4):519–526.
  • Shilling V, Starkings R, Jenkins V, et al. The pervasive nature of uncertainty—a qualitative study of patients with advanced cancer and their informal caregivers. J Cancer Surviv. 2017;11(5):590–603.
  • Dionne‐Odom JN, Hull JG, Martin MY, et al. Associations between advanced cancer patients’ survival and family caregiver presence and burden. Cancer Med. 2016;5(5):853–862.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.